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Abstract
Pancreatic islets are heavily vascularized in vivo with each insulin secreting beta-cell associated with at least one endothelial
cell (EC). This structure is maintained immediately post-isolation; however, in culture the ECs slowly deteriorate, losing
density and branched morphology. We postulate that this deterioration occurs in the absence of blood flow due to limited
diffusion of media inside the tissue. To improve exchange of media inside the tissue, we created a microfluidic device to
culture islets in a range of flow-rates. Culturing the islets from C57BL6 mice in this device with media flowing between 1 and
7 ml/24 hr resulted in twice the EC-density and -connected length compared to classically cultured islets. Media containing
fluorescent dextran reached the center of islets in the device in a flow-rate-dependant manner consistent with improved
penetration. We also observed deterioration of EC morphology using serum free media that was rescued by addition of
bovine serum albumin, a known anti-apoptotic signal with limited diffusion in tissue. We further examined the effect of flow
on beta-cells showing dampened glucose-stimulated Ca
2+-response from cells at the periphery of the islet where fluid
shear-stress is greatest. However, we observed normal two-photon NAD(P)H response and insulin secretion from the
remainder of the islet. These data reveal the deterioration of islet EC-morphology is in part due to restricted diffusion of
serum albumin within the tissue. These data further reveal microfluidic devices as unique platforms to optimize islet culture
by introducing intercellular flow to overcome the restricted diffusion of media components.
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Introduction
Pancreatic islets are highly vascularized micro-organs designed
to effectively sense glucose and secrete insulin directly into the
bloodstream. The characteristically dense vasculature of islets is
comprised of endothelial cells (ECs) that are thin and highly
fenestrated, and therefore directly connect the insulin secreting
beta-cells to the blood [1]. Islets maintain this vasculature once
harvested for ex vivo studies. However, it is well established that
during ex vivo culture, the density of intra-islet ECs decreases
approximately 50% in the first day and is almost completely gone
by day four [2]. This loss of ECs during culture severely limits
long-term study of the interaction between beta-cells and ECs in
the tissue, and is directly relevant to the treatment of type 1
diabetes due to the critical role of the ECs from donor islets in the
revascularization of this tissue during transplantation [2,3,4]. The
final reconnecting vessels are formed by EC from the donor and
recipient, which makes it vital to maintain these cells prior to
transplantation [2,4]. Our goal was therefore to delay the loss of
islet-ECs during culture.
Islets isolated from the pancreas are severed from the
vasculature and once in culture rely on diffusion for nutrient
supply and by-product removal. We postulate that the ECs inside
islets in culture die in part due to an absence of blood flow to
provide media exchange. It is well established that ECs in culture
undergo apoptosis when serum is reduced in the culture medium
[5]. However, in isolated islets, serum proteins such as albumin
will not diffuse significantly into the tissue due to large
hydrodynamic radius and transient binding properties [6].
Alternatively, any nutrients that are consumed (eg. O2, glucose)
or products that are secreted (eg. insulin, lactate) will form
gradients that may adversely affect the ECs. Overall, limited
media exchange during islet culture can have detrimental effects
on the ECs within the islet. It should also be noted that flow-
induced shear can have a positive effect on ECs, acting as a
biomechanical stimulus and anti-apoptotic signal [7,8,9]. Con-
versely, flow can negatively affect epithelial cells [10], and may
therefore negatively impact glucose-stimulated insulin secretion.
To test the effect of fluid flow on maintenance of islet ECs, we
developed a hemodynamic environment using a custom-designed
microfluidic device. Our devices place islets in laminar flow,
similar to devices previously used to monitor bulk islet O2-
consumption rate using perfusion column chambers [11,12,13]. In
contrast to perfusion column designs, microfluidic devices require
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compatible with fluorescence microscopy [14,15]. We aimed to
use these devices combined with fluorescence microscopy to treat
islets with media flow and image the effect on ECs and beta-cells.
Materials and Methods
Microfluidic Device Fabrication
Devices were fabricated using elastomer polydimethylsiloxane
(PDMS) (Dow-Corning) as described previously [16,17]. The
cured mould was irreversibly bonded to a 24650-mm coverslip
(VWR Scientific) by oxygen plasma treatment (Harrick Scientific,
Ossining, NY) and Tygon tubing was inserted directly into the
cored-out port holes.
Microfluidic Device Design
The microfluidic device design and process are described in
detail in the Supplemental Material (Text S1 & Fig. S1, S2, and
S3). Briefly, islets were brought into 125 mm tall 6300 mm wide
microfluidic channels through inlet port tubes. Islets moved along
these channels by media flow until they reached a dam wall. This
dam structure was 25 mm tall, 1,800 mm wide, and 0.13 cm long,
and allowed solution to flow past but blocked the movement of
islets. Microfluidic devices provide only non-turbulent or laminar
flow at the flow rates used in these studies [14]. Two main designs
were used for these studies: a three-channel microfluidic device
and an independent-channel microfluidic device (Fig. S1). The
three-channel device placed islets in three different flow-rates
based on varied channel lengths and by using a single syringe
pump. The independent-channel device provided a single flow-
rate in parallel channels to facilitate subsequent live cell imaging or
effluent collection.
Ethics Statement
Animal procedures were approved by the Animal Care
Committee of the University Health Network, Toronto, Ontario,
Canada in accordance with the policies and guidelines of the
Canadian Council on Animal Care (Animal Use Protocol #1531).
Pancreatic Islet Isolation and Treatment
Pancreatic islets were isolated from 8- to 12- week-old C57BL6
male mice by using collagenase digestion (Roche) [18,19]. Islets
were cultured in RPMI medium 1640 containing 11 mM glucose,
10% FBS, 5 U/ml penicillin-streptomycin, and 20 mM HEPES.
Control islets were incubated in a non-treated culture dishes in a
humidified incubator at 37uC and 5% CO2. Device-treated islets
were loaded into the microfluidic devices shortly after isolation and
incubated in a custom-built desk-top incubator described in detail
in the Supplemental Material (Fig. S2). Briefly, the microfluidic
device was submerged in a stirred water bath at 37uC with flow
driven by a syringe pump. The reservoir media was also
submerged in a separate water-bath maintained just above 37uC
to reduce formation of air bubbles in the microfluidic channel. A
cap of mineral oil was placed on top of the media in the reservoir
to reduce evaporation and drift in pH.
Immunofluorescent Detection
Control and device-treated islets were labelled within the
microfluidic device. Islets were fixed (2% PFA, PBS, 1 hr, 100 mL/
hr), blocked (PBS, 0.1% TritonX-100, 4uC, 10% Normal Goat
Serum, 4 hr, 15 mL/hr), incubated with primary antibody (PBS,
0.1% TritonX-100, 4uC, 1% Normal Goat Serum, 1:100 dilution
rat anti-mouse PECAM-1, 3 hr, 3 mL/hr), rinsed (PBS, 0.1%
TritonX-100, 4uC, 10% Normal Goat Serum, 1 hr, 15 mL/hr)
and incubated with 1:500 goat anti-rat Alexa 633 (PBS, 0.1%
TritonX-100, 4uC, 10% Normal Goat Serum, 3 hr, 15 mL/hr).
Islets were imaged using a 2060.50 NA objective lens in 3 mm
steps for 16–20 slices (dependant on the size of the islet) on an
Olympus FluoView 300 microscope.
Images were analyzed using ImageJ 1.41o (Wayne Rasband,
NIH, USA). EC fractional area was measured by calculating the
area of PECAM-1 labelling divided by the total area of the islet (6
slices/islet). Total connected length was determined using Simple
Neurite Tracer throughout the entire stack of images. PECAM-1
labelled regions were tracked through the stack and the resulting
summation was normalized to the circumference of the islet. The
average of individual islets was used for statistical analysis. A two
tail, unpaired, two sample student’s t-test was used and significance
was determined with p,0.05 (*) and p,0.01 (**).
Islet intracellular calcium
Islets were preincubated with either 4 mM of Fura-2 or Fluo-4 in
imaging buffer supplemented with 2 mM glucose for 1–2 hr prior
to imaging. Fura-2 images were collected using the 4061.3 NA oil
immersion lens of an Eclipse Ti-S inverted microscope with
340 nm and 380 nm excitation and 510640 nm emission filter
(PTI EasyRatioPro System, USA). Fluo-4 images were collected
on an LSM710 Microscope, 2060.80 NA objective lens, 488-nm
laser line, and 493–630 nm emission. The device and its reagents
were placed on the microscope stage inside a 37uC stage-top
incubator (Okolabs).
Two-photon NAD(P)H Imaging
NAD(P)H imaging was done as previously described using a
4061.3 NA oil immersion objective lens and internal detector
(385–550 nm) of a LSM710 microscope (Zeiss) [20,21]. The
Ti:Saph laser was tuned to 705 nm and attenuated to ,3m Wa t
the sample (Coherent).
Insulin Secretion
Islets in a single channel were stimulated with 200 mL/hr flow
and 37uC. Islets were subsequently treated for one hour with
2 mM and 11 mM glucose, each providing 200 mL of effluent.
The flow rate was increased to 200 mL/min and 1% TritonX-100
introduced to release the total insulin content. The effluents were
diluted 506(2 and 11 mM glucose) and 2006(1% TritonX-100)
prior to insulin ELISA detection.
Results
A Microfluidic Device to Mimic in vivo Hemodynamics
Islets placed in culture no longer experience blood flow. To
introduce intracellular flow, we developed a microfluidic device for
long-term culture (Fig. 1 & S1). Similar to our previous
microfluidic device designs, islets were trapped at a channel dam
(Fig. 1A & B) [22]. The dam was fashioned by dropping the
channel height from 125 to 25 mm, effectively preventing islets
from moving further down the channel while still allowing fluid to
flow. The device shown had three channels of varying length with
individual inputs and one common output (Fig. 1C). This design
allowed us to culture islets in three different flow-rates using a
single syringe pump.
To measure the effect of time (0, 24, and 48 hr) and flow rate
(no flow and flow between 1 and 7 ml/24 hr) on EC morphology,
islets cultured in dishes (no flow) or in the three channel
microfluidic device were assessed by immunofluorescence imaging
of PECAM-1 (Fig. 2). These flow rates were chosen to
approximate a physiologically relevant range of shear stress (1–
Pancreatic Islet Culture in a Microfluidic Device
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2) based on the device geometry [23]. In comparison,
individual rat islets in vivo receive ,0.03 ml/24 hr of blood flow
[24,25]. Islets fixed immediately post-isolation were heavily
vascularised with EC that branched throughout the islet
(Fig. 2A). The morphology of the ECs in control dish-cultured
islets changed significantly in 24 hr, appearing to coalesce
(Fig. 2B) [2]. In contrast, the ECs of islets treated in the device
with flow had greater density and vascular structure throughout
the islet compared to control (Fig. 2C). To quantify these changes
in morphology, we measured the average relative length and
fractional area of the ECs in a number of islets (Fig. 2D–F). After
24 and 48 hr of culture, the length and area was significantly
decreased in both control and device-treated islets compared to
freshly isolated islets (Fig. 2D & E, Day0 vs. Cntl(0)). However,
we observed significantly denser and longer ECs in islets cultured
in the device at each time point compared to control islets. We also
measured a dramatic decline in EC density at extreme flow rates
(0.9860.08 and 1.1660.10 fold-EC fractional area at 0.3 and
30 ml/24 hr compared to control, respectively) consistent with an
envelope of optimal flow rate. Even though microfluidic devices
are inherently permeable to oxygen [26] and we are flowing at
rates normally experienced in vivo (0.03 ml/24 hr/islet) [24,25],
we may be limiting nutrient supply (glucose, O2) at 0.3 ml/24 hr.
We may also be inducing shear damage to the tissue at 30 ml/
24 hr. To explore the effect of islet size on EC morphology, we re-
examined the data shown in Figure 2E based on islet diameter
(Fig. 2F). Grouping the data from large and small islets (defined as
above and below the median islet diameter (178 mm), respectively),
we observed no difference in EC fractional area of freshly isolated
islets (Day0). After 48 hrs of culture in the absence of flow, large
islets had significantly lower EC fractional area than small islets.
These data are consistent with a more significant loss of EC
morphology in large islets. In contrast, culturing islets in flow (1–
7 ml/24 hr) resulted in no difference in EC fractional area
between large and small islets, consistent with flow-rate rather
than islet size determining EC morphology. Overall, these data
show that islets treated to media flow in the device (1–7 ml/24 hr)
maintained more than twice their EC density and connected
length when compared to islets traditionally cultured in the
absence of flow.
The Mechanism of Enhanced Morphology
To determine where media gained access in the tissue, we
cultured islets in flow (3 ml/24 hr) for 24 hr and subsequently
imaged media supplemented with fluorescent dextran (Fig. 3A &
B). These and subsequent studies were done using a single channel
microfluidic device with on-chip reservoir, which allowed us to
quickly exchange the media (Fig. S3). Fluorescent dextran does
not enter living cells, and therefore reports on the volume of media
in the intercellular space. We observed media surrounding each
individual cell as well as filling connected pathways that had
similar shape to ECs (Fig. 3A & B). By fixing and staining these
same islets for PECAM-1, we further confirmed that the
connected pathways corresponded to the ECs of the islet
(Fig. 3A & C, arrows). These data show that media can access
the cells in the center of the islet; however, our PECAM-1 data
(Fig. 2) suggested that this access is limited at slower flow rates
(0.3 ml/24 hr). To examine the flow-rate dependence of media
penetration, we measured the time to fill the intercellular space at
Figure 1. A microfluidic device to treat pancreatic islets with
laminar flow. (A) A schematic of a microfluidic channel is shown to
demonstrate how pancreatic islets are held in laminar flow. Pancreatic
islets (oval) are brought into microfluidic channels (outlined) and
trapped when the channel height drops from 125 to 25 mm. This stops
the islet from moving down the channel while allowing fluid to flow
past the islet (arrows). (B) A representative image of islets held at the
‘pea pod’ shaped dam in a channel. In this experiment, the islets were
cultured for 24 hr prior to loading. The islets are sitting in the tall
channel (125 mm) against the dam wall to the right. Flow in the device
is past the islets from left to right. (C) An image of the three channel
microfluidic device used for varying fluid flow-rates past islets. The
device shown is filled with bromophenol blue solution to highlight the
channels and tubing. The device has three individual inputs (tubing)
with a common output (not shown). The three microfluidic channels
(125 mm) each have a dam for islet retention (spherical region,2 5mm)
followed by varying lengths of output channels (125 mm). These varied
channel lengths allowed media flow to be controlled with one syringe
pump, and media flow at three different flow-rates relative to length.
Flow rates were ultimately determined by measuring the height of the
input reservoirs before and after incubation.
doi:10.1371/journal.pone.0024904.g001
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PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24904Figure 2. The effect of fluid-flow on EC area and connected length. Pancreatic islets were cultured in either the microfluidic device with flow
(device-treated) or in non-flowing media in an incubator (control) followed by anti-PECAM-1 immunolabelling. (A) A representative Day 0, freshly
isolated islet shows heavy vascularization of the tissue prior to culture. (Scale bar 125 mm) (B) A representative control islet cultured in no-flow for
24 hr displaying characteristic coalescence of EC. (Scale bar 100 mm) (C) A representative islet cultured for 24 hr in a microfluidic device displaying
increased EC density and connected length compared to control islets (Cntl(0)). (Scale bar 150 mm) (D) The total EC connected length relative to the
circumference (EC Length L/c) of freshly isolated islets (hatched bar), control islets (Cntl(0)) at 24 (black bars) and 48 hr (open bars), and device-treated
islets exposed to fluid flow (1–3, 3–5, and 5–7 ml/24 hr). (E) The EC area relative to islet area (EC percent area) of freshly isolated islets (hatched bar),
control islets (Cntl(0)) at (24 (black bars) and 48 hr (open bars), and device-treated islets exposed to fluid flow (1–3, 3–5, and 5–7 ml/24 hr). The EC
length and fractional areas were measured from the islets isolated from at least 3 different mice on independent days. The data shown is the mean 6
sem for the following number of pooled islets: 43 (Day0), 14 (Control, 24 hr), 12 (24 hr, 1–3 ml/24 hr), 19 (24 hr, 3–5 ml/24 hr), 10 (24 hr, 5–7 ml/
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shown of a single islet as fluorescent dextran is introduced at a flow
rate of 3 ml/24 hr from right to left. In this setup, we measured
the time between dye front arrival (as dye surrounds the islet) and
dye filling the intercellular space. The top panel of Fig. 3D is the
image frame immediately prior to the arrival of dye at the islet
(0 s). At this time the media and islet are both dark reflecting the
absence of dye. At 2 s the dye completely filled the channel, but
the islet remained dark indicating the dye had not significantly
penetrated the tissue. The visibly dark flow tail streaming behind
the islet (at left) occurs due to non-fluorescent media being pushed
from the intercellular space. By 30 s, the dye completely filled the
intercellular space of the islet and the clear flow stream
disappeared. Data collected from multiple islets at multiple flow
rates shows that the time for dye to penetrate the islet is
exponentially dependent on flow rate (Fig. 3E). These data
suggest that at the flow rates previously shown to enhance EC
morphology (3–6 ml/24 hr), media exchange occurs in less than
30 s. In contrast, at flow rates that did not enhance EC
morphology (0.3 ml/24 hr) media exchange was a least 56slower
(.150 s). Importantly, this graph is asymptotic as it approaches
0 ml/24 hr, indicating that in normal static culture the exchange
rate due to diffusion is likely much slower (min - hrs). We also re-
grouped the data based on islet size, but observed no differences in
dye penetration at any of the flow rates between large and small
islets. This result was consistent with our previous data showing a
24 hr), 16 (Control, 48 hr), 10 (48 hr, 1–3 ml/24 hr), 7 (48 hr, 3–5 ml/24 hr), and 7 (48 hr, 5–7 ml/24 hr). (F) The EC fractional area for the data shown
in Fig. 2E re-grouped into large and small islets based on the median diameter (178 mm). Data shown are the mean 6 sem for the following number
of pooled islets: 21 (Large Islets, Day0), 22 (Small Islets, Day(0)), 9 (Large Islets, Cntl(0)), 8 (Small Islets, Cntl(0)), 12 (Large Islet, 1–7 ml/24 hr), and 12
(Small Islets, 1–7 ml/24 hr). The * and ** indicate p,0.05 and p,0.01 compared to control (Cntl(0)) or where otherwise indicated.
doi:10.1371/journal.pone.0024904.g002
Figure 3. Media access in a microfluidic device measured using fluorescent dextran. To explore the nature of the fluid flow inside treated
islets, real-time fluorescent imaging was applied to 24 hr device-treated islets (3 ml/24 hr). (A) We flowed fluorescent dextran (3,000 MW) into the
microfluidic device and imaged penetration of this dye into the tissue. The dye fills the channel and intercellular spaces of the islet. Connected (path-
like) regions that resemble islet-EC morphology (arrow) were immediately evident (black scale bar=40 mm). (B) A magnified image shows that
fluorescent dextran surrounds each cell in the islet (Scale bar=15 mm). (C) These same islets were immunofluorescently labelled for ECs using PECAM-
1 immunofluorescence. The connected regions identified by fluorescent dextrans co-labelled as ECs (compare arrows in A and C) (Scale bar=40 mm).
(D) To measure the kinetics of fluorescent dextran exchange with the intercellular space, we examined the arrival of the dye as it was introduced into
the channel. A typical time series is shown with media flowing 3 ml/24 hr from the right to left. The images shown were acquired at 0, 12, and 101 s
after the arrival of fluorescent dextran to the islet until it eventually fills both the channel and intercellular space. In the absence of dye, the channel
and islet are dark (0 s). At 12 s after the dye arrival, the channel had filled with dye except for a tail of non-labelled solution pushed from the
unlabelled islet. At 101 s after the dye arrival, the intercellular spaces were clearly visible and the dye completely filled the channel. (E) To determine
the dependence of media exchange on flow rate, we measured the time required to penetrate the islet at various flow rates. These data were
collected from the islets of 4 separate mice on different experimental days. The data is plotted as mean clearance time 6 sem for the pooled islet
data. (F) Islets were cultured in non-flowing media for less than 24 hr prior to imaging. Fluorescent dextran images were collected in a sequence
similar to (D), but with spatial resolution similar to (A). This imaging sequence allowed us to measure the intensity of fluorescent dextran at EC
structures (EC, black line) or neighbouring intercellular spaces (Intercellular, grey line). The arrow indicates the arrival of fluorescent dextran at the
islets. The fractional intensity was determined from the intensity at time zero and the maximal intensity reached at each region at .100 s. Data are
shown from the average 6 sem for 90 neighbouring pairs of regions from 7 different islets. No difference in arrival rate was measured between EC
and intercellular spaces indicating no preference for flow through the lumen of the ECs.
doi:10.1371/journal.pone.0024904.g003
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also consistent with dye penetration being more a function of flow
rates in the microfluidic device than of islet size. To determine the
route of flow, we also measured fluorescent dextran arrival in
neighbouring intercellular and EC-regions spaces in a number of
islets (Fig. 3F). These data show identical arrival times indicating
flow in the device is not preferentially driven through the EC
lumen, but rather simply through intercellular spaces.
Serum albumin is a potent anti-apoptotic signal to endothelial
cells [5] that due to large hydrodynamic radius has restricted
diffusion into tissues [6]. To determine whether enhanced EC
morphology in microfluidic flow is due to improved access of serum
albumin, we compared islets cultured for 24 hr in a dish (control,
10% FBS) to islets a microfluidic device (3 ml/24 hr). The device
treated islets were maintained in media with normal serum (10%
FBS), no serum (Serum Free), or bovine serum albumin (4% BSA)
(Fig. 4). Representative images (Fig. 4A) and the quantified
morphology (Fig. 4B & C) againshowincreased ECfractional area
and length in device treated islets compared to control when
cultured in normal serum (10% FBS). In contrast, EC fractional
area and length were significantly decreased compared to control in
the absence of serum (Serum Free). Addition of bovine serum
albumin (4% BSA) resulted in a significant increase in EC fractional
area and length compared to control islets and similar responses
compared to device-treated islets with normal serum. These data
show that the improvement in islet-EC morphology normally
observed with in microfluidic flow is due in part to enhanced access
of serum albumin to the center of the tissue.
Beta-cell Function
We measured beta-cell function in multiple ways to determine
the effect of flow. Large islets in culture often develop a necrotic
core visible under the white light of a microscope. We therefore
counted the number of necrotic centers observed in all of our
experiments after 48 hrs of culture. Of the 114 islets cultured in a
dish, 10 (or 8.8%) developed a necrotic core. In contrast, we did
not see a single necrotic core in 50 islets cultured at 3 ml/24 hr for
48 hr. These data are consistent with improved penetration of
media to the center of islets when treated with flow in the device.
In our design, beta-cells on the periphery of the islet experience
the greatest shear stress since they are subjected to the highest flow
rates. To evaluate the functionality of the beta-cells of device-
treated islets, we measured the intracellular [Ca
2+]-response to
glucose challenge and membrane depolarization using Fura-2
(Fig. 5). Fura-2 is an acetoxymethyl (AM) dye that due to
restricted diffusion mainly reports on responses from peripheral
cells of tissue. Both control and device-treated islets had low non-
oscillatory [Ca
2+]-responses at 2 mM glucose (340:380 nm ratio),
which is well below the normal response threshold (Fig. 5A). In
contrast, control islets showed a significant rise in [Ca
2+]a t
11 mM glucose that was not present in device-treated islets
(Fig. 5A, B & C), and both showed a consistent response to KCl-
induced membrane depolarization (Fig. 5A & D).
To measure [Ca
2+]-oscillation synchrony, islets were labelled
with Fluo-4 and imaged using a confocal microscope (Fig. 6) [17].
These cross-sectional images show that like other AM-dyes Fluo-4
only labels a few cell layers deep into tissue near the periphery
Figure 4. Effect of serum albumin on EC morphology. Islets were cultured for 24 hr in normal culture (Control, 10% FBS) and the microfluidic
device (3 ml/24 hr flow rate). The media used in the device was either normal media (10% FBS), serum free media (Serum Free) or serum free media
containing 4% bovine serum albumin (4% BSA). The islets were then fixed and immunofluorescently labelled for PECAM-1. (A) Representative
maximum projection image of PECAM-1 immunofluorescence for each culture. (B) EC Percent Area of control islets (open bar) and device treated
islets (black bars) cultured as indicated. (C) The relative EC length of control islets (open bar) and device treated islets (black bars) cultured as
indicated. Each bar consists of the data collected from 10 to 17 islets collected from 3 mice, with the islets from each mouse isolated on independent
days. The * and ** indicate p,0.05 and p,0.01 compared to control (open bar, 10% FBS), respectively by two-tailed student’s t-test.
doi:10.1371/journal.pone.0024904.g004
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are shown in these representative images (Fig. 6A & B, arrows)
with normalized intensities (F/F0) plotted (Fig. 6C–F). At 2 mM
glucose, control and device-treated islets showed a flat [Ca
2+]-
profile consistent with our Fura-2 data (Fig. 6C & D). In contrast
and also consistent with our Fura2 data, 11 mM glucose caused
oscillations only in the control islets (Fig. 6E & F). Overall, our
data indicate a muted glucose-stimulated [Ca
2+]-response from the
periphery of device-treated islets, but that the islets are not
damaged to the point of being electrically active at low glucose.
To investigate the activity of all the cells in the islet and not just
those at the periphery, we imaged the glucose-stimulated
metabolic response using two-photon imaging of the NAD(P)H
response and also measured glucose-stimulated insulin secretion
(Fig. 7). Two-photon imaging of NAD(P)H autofluorescence
allows us to measure the redox state of living pancreatic islets with
high spatial resolution [17,20,21,22]. More specifically, islets
cultured for 48 hr in control and microfluidic device-flow (3 ml/
24 hr) were imaged in 2 and 20 mM glucose (Fig. 7A). The
representative images were collected ,20 mm deep into the tissue
to provide a cross-section through the islet. Control islets in 2 mM
glucose exhibit even autofluorescence across the tissue (Fig 7A,
top left). In contrast, many of the device-treated islets at 2 mM
glucose had higher intensity in the peripheral cells consistent with
our previous experience that islets increase base line NAD(P)H
when stressed (Fig. 7A, top right) [17]. Challenging the islets
with glucose raised NAD(P)H intensity in both control and device-
treated islets, consistent with a normal response in the majority of
central beta-cells. On average, control and device-treated islets
showed a similar ,1.7-fold increase in NAD(P)H intensity
(Fig. 7B). Importantly, these responses were collected from the
central cells to avoid the brighter less responsive peripheral
regions. To determine whether this metabolic response translates
to normal overall insulin secretion, the glucose-stimulated insulin
Figure 5. Measuring beta-cell [Ca
2+]-activity using Fura-2. Islets subjected to 48 hr of fluid-flow (3 ml/hr) followed by labelling with Fura-2 to
evaluate beta-cell [Ca
2+]-responses. (A) Typical control and device-treated islets at 2 mM glucose displayed a consistent flat base-line [Ca
2+]-response.
After the addition of 11 mM glucose, control islets displayed normal [Ca
2+]-oscillations while the device-treated response was small and flat. Data is
representative of the response from a total of 11 islets from N=3 mice, with the islets from each mouse isolated on independent days. (B) Control
islets typically displayed fast Ca
2+-oscillations at 11 mM glucose while the response of device treated islets was flat. (C) The change in 340:380 nm
ratio is the transition from 2 to 11 mM glucose in control and device-treated islets. (D) The change in 340:380 nm ratio transitions from 11 mM
glucose to 30 mM KCl in control and device-treated islets. The similar 30 mM KCl response delta indicates similar electrical activity in response to
membrane depolarization. Each bar consists of the data collected from a total of at least 6 islets from 3 mice, with the islets from each mouse isolated
on independent days. The * indicates p,0.05 compared to control by two-tailed student’s t-test.
doi:10.1371/journal.pone.0024904.g005
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(3 ml/24 hr) after 48 hr culture. This study used a single channel
microfluidic device to allow analysis of the insulin in the effluent
from islets subsequently stimulated with 2 mM and 11 mM
glucose (Fig. 7C). The device-treated islets showed a steady rise in
glucose-stimulated insulin secretion that was similar to control
islets, suggesting a normal glucose-stimulated response. Overall,
these data show that device-treated islets maintain their glucose-
stimulated metabolic and insulin responses, and suggest that flow
damage is limited to the peripheral cells.
Discussion
Our data show that isolated pancreatic islets treated to media
flow in a microfluidic device preserve EC density and connected
length better than islets maintained in non-flowing traditional
culture. Our data also show that the positive effect is due to
intercellular flow improving serum albumin access to the center of
the islet. While media flow dampened the glucose-stimulated
[Ca
2+]-response, this effect is limited to the peripheral beta-cells
with normal glucose-stimulated two-photon NAD(P)H response
and insulin secretion. Overall, these data indicate that microfluidic
devices are a promising platform for long-term culture and
maintenance of ex vivo pancreatic islets.
Previous studies used perfusion chambers to culture islets in
laminar flow while sampling bulk O2 consumption rate [11,12,13].
In contrast, our setup allowed us to image the tissue using
fluorescence microscopy (PECAM-1 immunofluorescence, Ca
2+-
response, two-photon NAD(P)H) and examine the effect of media
flow on the ECs of individual islets. The ECs of mature blood
Figure 6. Monitoring synchronous beta-cell [Ca
2+]-response in pancreatic islets using Fluo-4. Islets were cultured in control or
microfluidic device flow (3 ml/24 hr) for 48 hr prior to labelling with Fluo-4. The dye labels cells as the periphery of the islet as observed using
confocal microscopy by a ring of labelled cells. Representative control (left, A) and device-treated (right, B) islets are shown, each with three regions of
interest (ROI) that are subsequently plotted in (C–F) (Scale bar 120 mm, 90 mm respectively). (C & D) At 2 mM glucose, the [Ca
2+]-response is flat as
expected in both the control (left, C) and device-treated islets (right, D). (E & F) At 11 mM glucose, [Ca
2+]-oscillations were synchronous in functioning
control islets (E, compare ROI 1, 2 and 3); however, no [Ca
2+]-oscillations were observed in the device-treated islets (F) suggesting moderate damage
to the periphery of the islet.
doi:10.1371/journal.pone.0024904.g006
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with tight cell-cell junctions [9,27]. This morphology and cell-cell
junction formation is a critical regulator of EC growth and
apoptosis [7,28]. We and others have shown that EC morphology
in culture slowly deteriorates with cells initially coalescing followed
by a reduction in overall number over a period of days. In
contrast, device-treated islets maintained significantly greater EC
area and connected length compared to control islets.
We narrowed the effect of microfluidic device culture to
improved access of serum albumin through the intercellular
spaces. Individual rat islets in vivo are normally exposed to
,0.03 ml/24 hr of blood containing serum albumin [24,25].
Serum albumin is an anti-apoptotic signal for ECs that has
restricted diffusion in tissue due to a large hydrodynamic radius. In
the absence of flow, access of serum albumin depends solely on
diffusion. Our data are consistent with flow in the device
overcoming limited diffusion to stimulate the ECs within the
tissue. We also observed a significant reduction in necrosis in flow-
treated islets. It should be noted that even with serum albumin
gaining access, we only partially maintained EC morphology with
significant loss in density and length still observed compared to
freshly isolated islets. To improve these responses, we propose
further optimization of our media including addition of angiogenic
factors that may have previously shown limited effect due to poor
tissue penetration.
Although we used linear flow velocities (2–6 cm/min) similar to
other perfusion columns, our microfluidic device has a significantly
smaller cross-sectional area (0.04 mm
2 vs. 4.9–55 mm
2)
[11,12,13]. This creates a much higher fluidic resistance down
the channel. By calculating the fluidic-resistance the length of a
typical islet (100 mm), we estimate that islets experience a drop in
pressure of ,10
25 kPa along their length when cultured at 3 ml/
24 hr. This drop forces media to flow through the islet rather than
simply around it consistent with improved serum albumin access
and reduced necrosis. In flow greater than 3 ml/24 hr, media
exchange inside the islet occurred in less than 30 s. However, we
observed an asymptotic increase in the time to clear the islet below
3 ml/24 hr indicating we are at the threshold pressure required to
induce significant intercellular flow. In contrast, we estimate that
in larger perfusion columns with 4.9–12.6 mm
2 cross sectional
area, islets experience 200 to 5000-fold smaller pressure drop
across the islet and are therefore not likely to induce significant
flow in the intercellular space. More recently, microfluidic devices
have been designed for short-term culture prior to transplantation;
however, these devices are specifically designed to hold the islets in
a reservoir with minimal flow and likely do not cause significant
intercellular media-flow [29].
Beta-cells respond to glucose through metabolic closure of ATP-
sensitive potassium channels (KATP), membrane depolarization,
[Ca
2+]-influx through voltage gated calcium channels, and insulin
Figure 7. Glucose-stimulated NAD(P)H and insulin responses.
Islets were cultured in control conditions or in microfluidic device flow
(3 ml/24 hr) for 48 hr. (A) Control and flow treated islets were
subsequently treated with 2 and 20 mM glucose and imaged using
two-photon excitation of NAD(P)H. Scale bar in top left panel is 50 mm.
(B) The fold NAD(P)H intensity from control and device treated islets.
Data shown is the mean 6 sem for 21 and 24 islets collected from 3
separate mice on independent days. The * indicates p,0.05 compared
to control by two-tailed student’s t-test. (C) Islets were cultured in
control or in microfluidic device flow (device, 3 ml/24 hr) for 48 hr. The
control islets were placed in a microfluidic device and both control and
flow treated islets were subsequently treated with 2 mM glucose
followed by 11 mM glucose in imaging buffer. The paired effluent was
collected from each channel containing 4–6 islets. Insulin levels were
then normalized to total insulin per channel using effluent collected
with Triton X-100 permeabilization. A comparison between control and
device-treated islets shows similar basal insulin levels with an increase
in secretion at the higher glucose concentration. The data shown are
from duplicate channels from 4 mice collected on independent days.
doi:10.1371/journal.pone.0024904.g007
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2+]-
response using two dyes, Fura-2 and Fluo-4, and observed a
robust [Ca
2+]-response to membrane depolarization. However,
the glucose-stimulated response of device-treated islets was muted
in comparison to control islets. We further examined the glucose-
stimulated metabolic response using two-photon excitation of
NAD(P)H autofluorescence. This technique provided a quantita-
tive measure of the glucose-stimulated metabolic response with
sufficient spatial resolution to determine the effect of flow on both
peripheral and central beta-cells. Consistent with the muted
[Ca
2+]-response, the peripheral cells showed a muted glucose-
stimulated NAD(P)H response. However, consistent with a normal
response from the remainder of beta-cells, the central cells of
device-treated islets had similar glucose-stimulated NAD(P)H
responses compared to control islets. Finally, device-treated islets
had similar glucose-stimulated insulin secretion compared to
control islets. Overall, our data suggest the majority of central
beta-cells maintain glucose-stimulated responses in the micro-
fluidic device, with minor damage to the peripheral cells.
We are particularly interested in using microfluidic devices to
study the communication between beta-cells and ECs via
extracellular matrix (ECM) deposition and remodeling. ECs are
primarily responsible for deposition of islet ECM, which directly
affects beta-cells by modulating cell survival, proliferation,
differentiation and insulin secretion through a number of
mechanisms [31,32]. We recently showed that beta-cell fibroblast
growth factor receptor-1 (FGFR1) expression and signaling are
altered by the ECM, suggesting activity can be modulated by EC-
interaction to effect proliferation and glucose-stimulated insulin
secretion [33]. Our microfluidic platform enhances the culture
lifespan of islet associated ECs, providing a controlled environ-
ment to study beta-cell-EC interaction.
Our results are also relevant to the treatment of type 1 diabetes
through transplantation of pancreatic islets following the Edmon-
ton Protocol [34]. This treatment has limited initial and long-term
efficacy with only 58% of patients gaining insulin independence
and 76% of patients requiring insulin after two years [35]. We
propose to improve revascularization efficiency by maintaining the
ECs during culture or alternatively ‘priming’ them prior to
transplantation. The flexibility of microfluidic device design allows
scale-up in the number of islets needed for transplantation (i.e.
increasing channel number). However, scaled-up versions will
need to maintain high pressure differential along the channel in
combination with low linear velocity. These studies will also need
to examine the effect of flow on the peri-islet capsule as it has been
postulated to act as a barrier to the immune response [36].
Supporting Information
Figure S1 Custom microfluidic devices to culture ex
vivo pancreatic islets in laminar flow. (A) A three channel
microfluidic device composed of PDMS, glass coverslip, and inlet-
and outlet-tubing. This device is designed to supply flow at varied
rates in the three independent channels. Bromophenol blue dye is
used to highlight the three separate channels with a common
output. (B) The flow-rate in each channel is determined by its
resistance, which is directly related to channel length. Each
channel has a unique input tubing, main channel, and dam
structure that is followed by an output channel of different length.
The outlet channels are ultimately connected to a single outlet
tube. This places a similar pressure differential (air to syringe
pump) across the different channels of the device. (C) By using a
single syringe pump, fluid is pulled through each channel at a
different rate during culture. This results in fluid being pulled from
the syringe reservoirs at different rates. The reservoir height
(before and after culture) was ultimately used to determine the
average flow-rate during culture in each channel. (D) The
normalized values of the actual flow rate (black bars) and
calculated relative resistance (open bars) of each channel are
shown in the absence of islets (N=5). (E & D) The design is
simplified to contain single independent channels with dam
structures. The input and output channels are identical in length.
This design provides multiple channels for high throughput/
parallel culture and limits loss due to air bubble occlusion. (Scale
bar A=10 mm, B=6 mm, C=15 mm, E=10 mm, F=2 mm).
(TIF)
Figure S2 A schematic of our process and the actual
bench-top microfluidic incubator. (A) A schematic repre-
sentation shows the variation of temperatures across the setup.
The syringe reservoir and microfluidic device are maintained at
44uC and 37uC, respectively. These temperatures take advantage
of the lower dissolvability of air in water at higher temperatures to
slightly degas the media prior to entering the microfluidic
channels. (B) A corresponding picture of the microfluidic device
setup shows two hotplates to control water bath temperature, one
with a thermocouple to guarantee a constant 37uC. Media
perfusion is accomplished with a single syringe pump (three
channel device) or multiple pumps (independent channel device).
The device and media reservoirs are submerged in their respective
water baths. The media in the syringe is capped with ,1c mo f
mineral oil to limit pH drift and evaporation, and the top of the
syringe reservoirs are covered with AirPore tape (3 M). Both
beakers are covered with plastic wrap to reduce evaporation from
the open water baths.
(TIF)
Figure S3 Measuring beta-cell physiology using an
independent channel microfluidic device. (A) The device
shown has four identical flow channels, and a secondary layer of
PDMS used to form on-chip wells for easy reagent switching. Islets
are cultured in this device as described previously followed by
subsequent removal of the input tubing. The removal of this
tubing starts flow from the on-chip wells with flow controlled by
the syringe pump connected to the output tubing (B) Islets were
labelled with Fura-2 in the device (4 mM, 200 mL/mL, 1 hr) and
transferred to the microscope stage for imaging. The transition
from 2 to 11 mM glucose is accomplished by changing the
,200 mL on-chip well. Islets in 11 mM glucose displayed a
normal [Ca
2+]-response. The addition of 30 mM KCl showed a
larger [Ca
2+]-spike consistent with membrane depolarization.
Note that the intervals of specific reagents are indicated with a
straight line (2–4 min, 36–38 min).
(TIF)
Text S1 Supplemental text. Detailed description of the
microfluidic device design and process.
(DOC)
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